Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Lopez, JN; Prieto-Tato, L; Escosa-Garcia, L; Bernardino, JI; Munoz, E; Diez, C; Carrasco, I; Ryan, P; Guillen-Martin, S; Ramos-Amador, JT; Navarro, ML; Holguin, A; Sainz, T.

Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2022; 91(4): 373-380 Nº de citas: 3 [doi:10.1097/QAI.0000000000003070]

Baptista, MJ; Tapia, G; Munoz-Marmol, AM; Muncunill, J; Garcia, O; Montoto, S; Gribben, JG; Calaminici, M; Martinez, A; Veloza, L; Martinez-Trillos, A; Aldamiz, T; Menarguez, J; Terol, MJ; Ferrandez, A; Alcoceba, M; Briones, J; Gonzalez-Barca, E; Climent, F; Muntanola, A; Moraleda, JM; Provencio, M; Abrisqueta, P; Abella, E; Colomo, L; Garcia-Ballesteros, C; Garcia-Caro, M; Sancho, JM; Ribera, JM; Mate, JL; Navarro, JT.

Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

HISTOPATHOLOGY. 2022; 81(6): 826-840 Nº de citas: 10 [doi:10.1111/his.14798]

Cabello-Ubeda, A; de Quirós JCLB; Martín Carbonero L; Sanz, J; Vergas, J; Mena, A; Torralba, M; Hernández Segurado M; Pinto, A; Tejerina, F; Palmier, E; Gutierrez, A; Vazquez, P; Pulido, F; Gorgolas, M.

48-Week effectiveness and tolerability of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral-naive adults living with HIV: A multicenter real-life cohort

PLoS One. 2022; 17(11): Nº de citas: 6 [doi:10.1371/journal.pone.0277606]

Alvaro-Meca, A; Sepulveda-Crespo, D; Resino, R; Ryan, P; Martinez, I; Resino, S.

Neighborhood environmental factors linked to hospitalizations of older people for viral lower respiratory tract infections in Spain: a case-crossover study

ENVIRONMENTAL HEALTH. 2022; 21(1): Nº de citas: 5 [doi:10.1186/s12940-022-00928-x]

Valencia, J; Troya, J; Lazarus, JV; Cuevas, G; Alvaro-Meca, A; Torres-Machado, J; Escobar, I; Canamares, I; Ryan, P.

Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugs

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. 2022; 34(10): 1-8 Nº de citas: 1 [doi:10.1080/09540121.2021.1967853]

Berenguer J.

Neutralizing antibodies for SARS-CoV-2 infection

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35: 16-19 Nº de citas: 1 [doi:10.37201/req/s03.04.2022]

Hontanon, V; Gonzalez-Garcia, J; Rubio-Martin, R; Diez, C; Serrano-Moragod, L; Berenguer, J.

Effect of HCV eradication on critical flicker frequency in HIV/HCV coinfected patients with advanced cirrhosis

REVISTA CLINICA ESPANOLA. 2022; 222(8): 479-485 [doi:10.1016/j.rce.2022.02.008]

Antela, A; Bernardino, JI; de Quiros, JCLB; Bachiller, P; Fuster-RuizdeApodaca, MJ; Puig, J; Rodriguez, S; Castrejon, I; Alvarez, B; Hermenegildo, M.

Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges

Infectious Diseases and Therapy. 2022; 11(5): 2017-2033 Nº de citas: 7 [doi:10.1007/s40121-022-00678-w]

de Mendoza, C; Perez, L; Fernandez-Ruiz, M; Pena, MJ; Ramos, JM; Richart, A; Piron, M; Rando, A; Miro, E; Reina, G; Encinas, B; Rojo, S; Rodriguez-Iglesias, AM; Benito, R; Aguilera, A; Trevino, A; Corral, O; Soriano, V.

Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2022; 122: 970-975 Nº de citas: 8 [doi:10.1016/j.ijid.2022.07.043]

Veintimilla, C; Catalan, P; Alonso, R; de Viedma, DG; Perez-Lago, L; Palomo, M; Cobos, A; Aldamiz-Echevarria, T; Munoz, P.

The relevance of multiple clinical specimens in the diagnosis of monkeypox virus, Spain, June

Eurosurveillance. 2022; 27(33): Nº de citas: 32 [doi:10.2807/1560-7917.ES.2022.27.33.2200598]

Fanciulli, C; Berenguer, J; Busca, C; Vivancos, MJ; Tellez, MJ; Dominguez, L; Domingo, P; Navarro, J; Santos, J; Iribarren, JA; Morano, L; Artero, A; Moreno, J; Rivero-Roman, A; Santos, I; Giner, L; Arminanzas, C; Montero, M; Manzardo, C; Cifuentes, C; Garcia, C; Galindo, MJ; Ferrero, OL; Sanz, J; de la Fuente, B; Rodriguez, C; Gaspar, G; Perez, L; Losa, JE; Force, L; Veloso, S; Martinez-Alfaro, E; Jarrin, I; De Miguel, M; Garcia, JG.

Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019

HIV MEDICINE. 2022; 23(7): 705-716 Nº de citas: 13 [doi:10.1111/hiv.13229]

Montejano, R; de la Calle-Prieto, F; Velasco, M; Guijarro, C; Queiruga-Parada, J; Jimenez-Gonzalez, M; Gonzalez-Ruano, P; Martinez, P; Goikoetxea, AJ; Ibarrola, M; Ciudad, M; Gutierrez, A; Torralba, M; Diaz-Brasero, A; Ryan, P; Marcelo, C; Diez, C; Ibarra, S; Merino, E; Estrada, V; Marcos, J; Novella, M; Rivera, MA; Ruiz-Munoz, M; de Miguel, M; Soler, L; Del Alamo, M; Moreno, S; Carcas, AJ; Borobia, AM; Arribas, JR.

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

CLINICAL INFECTIOUS DISEASES. 2022; 76(3): 116-125 Nº de citas: 12 [doi:10.1093/cid/ciac628]

Troya, J; Duenas, C; Irazola, I; de los Santos, I; de la Fuente, S; Gil, D; Hernandez, C; Galindo, MJ; Gomez, J; Delgado, E; Moreno-Garcia, E; Posada, G; Aldamiz, T; Iribarren, JA; Guerra, JM; Moran, MA; Galera, C; Fuente, J; Pelaez, A; Cervero, M; Garcinuno, M; Montero, M; Ceballos, F; Buzon, L.

Dolutegravir plus rilpivirine: benefits beyond viral suppression DORIPEX retrospective study

MEDICINE. 2022; 101(24): Nº de citas: 8 [doi:10.1097/MD.0000000000029252]

Cruz, R; Diz-de Almeida, S; de Heredia, ML; Quintela, I; Ceballos, FC; Lorenzo-Salazar, GM; Gonzalez-Montelongo, R; Gago-Dominguez, M; Porras, MS; Castano, JAT; Nevado, J; Aguado, JM; Aguilar, C; Aguilera-Albesa, S; Almadana, V; Almoguera, B; Alvarez, N; Andreu-Bernabeu, A; Arana-Arri, E; Arango, C; Arranz, MJ; Artiga, MJ; Baptista-Rosas, RC; Barreda-Sanchez, M; Belhassen-Garcia, M; Bezerra, JF; Bezerra, MAC; Boix-Palop, L; Brion, M; Brugada, R; Bustos, M; Calderon, EJ; Carbonell, C; Castano, L; Castelao, JE; Conde-Vicente, R; Cordero-Lorenzana, ML; Cortes-Sanchez, JL; Corton, M; Darnaude, MT; De Martino-Rodriguez, A; del Campo-Perez, V; de Bustamante, AD; Dominguez-Garrido, E; Luchessi, AD; Eiros, R; Sanabria, GME; Carmen Farinas, M; Fernandez-Robelo, U; Fernandez-Rodriguez, A; Fernandez-Villa, T; Gil-Fournier, B; Gomez-Arrue, J; Alvarez, BG; de Quiros, FGB; Gonzalez-Penas, J; Gutierrez-Bautista, JF; Herrero, MJ; Herrero-Gonzalez, A; Jimenez-Sousa, MA; Lattig, MC; Borja, AL; Lopez-Rodriguez, R; Mancebo, E; Martin-Lopez, C; Martin, V; Martinez-Nieto, O; Martinez-Lopez, I; Martinez-Resendez, MF; Martinez-Perez, A; Mazzeu, JF; Macias, EM; Minguez, P; Cuerda, VM; Silbiger, VN; Oliveira, SF; Ortega-Paino, E; Parellada, M; Paz-Artal, E; Santos, NPC; Perez-Matute, P; Perez, P; Perez-Tomas, ME; Perucho, T; Pinsach-Abuin, ML; Pompa-Mera, EN; Porras-Hurtado, GL; Pujol, A; Leon, SR; Resino, S; Fernandes, MR; Rodriguez-Ruiz, E; Rodriguez-Artalejo, F; Rodriguez-Garcia, JA; Cabello, FR; Ruiz-Hornillos, J; Ryan, P; Soria, JM; Souto, JC; Tamayo, E; Tamayo-Velasco, A; Taracido-Fernandez, JC; Teper, A; Torres-Tobar, L; Urioste, M; Valencia-Ramos, J; Yanez, Z; Zarate, R; Nakanishi, T; Pigazzini, S; Degenhardt, F; Butler-Laporte, G; Maya-Miles, D; Bujanda, L; Bouysran, Y; Palom, A; Ellinghaus, D; Martinez-Bueno, M; Rolker, S; Amitrano, S; Roade, L; Fava, F; Spinner, CD; Prati, D; Bernardo, D; Garcia, F; Darcis, G; Fernandez-Cadenas, I; Holter, JC; Banales, JM; Frithiof, R; Duga, S; Asselta, R; Pereira, AC; Romero-Gomez, M; Nafria-Jimenez, B; Hov, JR; Migeotte, I; Renieri, A; Planas, AM; Ludwig, KU; Buti, M; Rahmouni, S; Alarcon-Riquelme, ME; Schulte, EC; Franke, A; Karlsen, TH; Valenti, L; Zeberg, H; Richards, B; Ganna, A; Boada, M; de Rojas, I; Ruiz, A; Sanchez-Juan, P; Real, LM; Guillen-Navarro, E; Ayuso, C; Gonzalez-Neira, A; Riancho, JA; Rojas-Martinez, A; Flores, C; Lapunzina, P; Carracedo, A.

Novel genes and sex differences in COVID-19 severity

HUMAN MOLECULAR GENETICS. 2022; : 3789-3806 Nº de citas: 46 [doi:10.1093/hmg/ddac132]

Alejos, B; Diez, C; Galindo, MJ; Lopez, JC; Moreno-Garcia, E; Estrada, V; Poveda, E; Omar, M; Jarrin, I; Berenguer, J.

Progress in the quality of care for newly diagnosed people with HIV in Spain (2004-2019)

ANTIVIRAL THERAPY. 2022; 27(4): Nº de citas: 3 [doi:10.1177/13596535221112729]

Sepulveda-Crespo, D; Yelamos, MB; Diez, C; Gomez, J; Hontanon, V; Torresano-Felipe, F; Berenguer, J; Gonzalez-Garcia, J; Ibanez-Samaniego, L; Llop, E; Olveira, A; Martinez, J; Resino, S; Martinez, I.

Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis

BIOMEDICINE & PHARMACOTHERAPY. 2022; 150: Nº de citas: 4 [doi:10.1016/j.biopha.2022.113024]

Teira, R; Diaz-Cuervo, H; Aragao, F; Castano, M; Romero, A; Roca, B; Montero, M; Galindo, MJ; Munoz-Sanchez, MJ; Espinosa, N; Peraire, J; Martinez, E; De la Fuente, B; Domingo, P; Deig, E; Merino, MD; Geijo, P; Estrada, V; Sepulveda, MA; Garcia, J; Berenguer, J; Curran, A.

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Infectious Diseases and Therapy. 2022; 11(3): 1177-1192 Nº de citas: 2 [doi:10.1007/s40121-022-00630-y]

Carrasco, I; Olveira, A; Lancharro, A; Escosa, L; Mellado, MJ; Busca, C; Montes, ML; Diez, C; Alcolea-Ruiz, S; Navarro, ML; Sainz, T.

Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV

AIDS. 2022; 36(6): 805-814 Nº de citas: 10 [doi:10.1097/QAD.0000000000003170]